Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) EBT Margin (2016 - 2025)

Historic EBT Margin for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to 0.45%.

  • Marimed's EBT Margin rose 3800.0% to 0.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.04%, marking a year-over-year increase of 25100.0%. This contributed to the annual value of 2.51% for FY2024, which is 19300.0% up from last year.
  • According to the latest figures from Q3 2025, Marimed's EBT Margin is 0.45%, which was up 3800.0% from 1.46% recorded in Q2 2025.
  • Marimed's 5-year EBT Margin high stood at 35.01% for Q2 2021, and its period low was 24.76% during Q4 2023.
  • In the last 5 years, Marimed's EBT Margin had a median value of 2.47% in 2021 and averaged 5.44%.
  • Per our database at Business Quant, Marimed's EBT Margin soared by 535100bps in 2021 and then crashed by -324500bps in 2023.
  • Marimed's EBT Margin (Quarter) stood at 2.47% in 2021, then skyrocketed by 211bps to 7.69% in 2022, then tumbled by -422bps to 24.76% in 2023, then soared by 69bps to 7.69% in 2024, then soared by 94bps to 0.45% in 2025.
  • Its EBT Margin stands at 0.45% for Q3 2025, versus 1.46% for Q2 2025 and 6.82% for Q1 2025.